251 related articles for article (PubMed ID: 25286412)
61. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
62. A panel of three plasma microRNAs for colorectal cancer diagnosis.
Tan Y; Lin JJ; Yang X; Gou DM; Fu L; Li FR; Yu XF
Cancer Epidemiol; 2019 Jun; 60():67-76. PubMed ID: 30925282
[TBL] [Abstract][Full Text] [Related]
63. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.
Herreros-Villanueva M; Duran-Sanchon S; Martín AC; Pérez-Palacios R; Vila-Navarro E; Marcuello M; Diaz-Centeno M; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; José Lozano J; García-Cougil M; Martínez-Arranz I; Castells A; Gironella M; Arroyo R
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00003. PubMed ID: 30702491
[TBL] [Abstract][Full Text] [Related]
64. Identification of a four-microRNA panel in serum as promising biomarker for colorectal carcinoma detection.
Huang G; Wei B; Chen Z; Wang J; Zhao L; Peng X; Liu K; Lai Y; Ni L
Biomark Med; 2020 Jun; 14(9):749-760. PubMed ID: 32672054
[No Abstract] [Full Text] [Related]
65. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
66. Circulating serum miR-1246 and miR-1229 as diagnostic biomarkers in colorectal carcinoma.
Rafiee R; Razmara E; Motavaf M; Mossahebi-Mohammadi M; Khajehsharifi S; Rouhollah F; Babashah S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S383-S390. PubMed ID: 36510992
[TBL] [Abstract][Full Text] [Related]
67. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.
Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M
PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147
[TBL] [Abstract][Full Text] [Related]
68. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
[TBL] [Abstract][Full Text] [Related]
69. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
70. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
71. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
Wu L; Zheng K; Yan C; Pan X; Liu Y; Liu J; Wang F; Guo W; He X; Li J; Shen Y
BMC Cancer; 2019 Aug; 19(1):843. PubMed ID: 31455274
[TBL] [Abstract][Full Text] [Related]
72. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
[TBL] [Abstract][Full Text] [Related]
73. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
74. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.
Fayyad-Kazan H; Bitar N; Najar M; Lewalle P; Fayyad-Kazan M; Badran R; Hamade E; Daher A; Hussein N; ElDirani R; Berri F; Vanhamme L; Burny A; Martiat P; Rouas R; Badran B
J Transl Med; 2013 Feb; 11():31. PubMed ID: 23391324
[TBL] [Abstract][Full Text] [Related]
75. Discovery and Validation of Circulating Biomarkers of Colorectal Adenoma by High-Depth Small RNA Sequencing.
Roberts BS; Hardigan AA; Moore DE; Ramaker RC; Jones AL; Fitz-Gerald MB; Cooper GM; Wilcox CM; Kimberly RP; Myers RM
Clin Cancer Res; 2018 May; 24(9):2092-2099. PubMed ID: 29490987
[No Abstract] [Full Text] [Related]
76. Predictive power of circulating miRNAs in detecting colorectal cancer.
Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
[TBL] [Abstract][Full Text] [Related]
77. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.
Zheng G; Du L; Yang X; Zhang X; Wang L; Yang Y; Li J; Wang C
Br J Cancer; 2014 Nov; 111(10):1985-92. PubMed ID: 25233400
[TBL] [Abstract][Full Text] [Related]
78. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
[TBL] [Abstract][Full Text] [Related]
79. Circulating microRNAs as specific biomarkers for breast cancer detection.
Ng EK; Li R; Shin VY; Jin HC; Leung CP; Ma ES; Pang R; Chua D; Chu KM; Law WL; Law SY; Poon RT; Kwong A
PLoS One; 2013; 8(1):e53141. PubMed ID: 23301032
[TBL] [Abstract][Full Text] [Related]
80. Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients.
Fesler A; Jiang J; Zhai H; Ju J
Mol Diagn Ther; 2014 Jun; 18(3):303-8. PubMed ID: 24566942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
